fibrotic diseases Archives

Canna~Fangled Abstracts

Cannabinoid Receptor Agonists for the Potential Treatment of Pain, Neurological Disorders, Fibrotic Diseases, Obesity, and Many More

RETURN TO ISSUEPREVPATENT HIGHLIGHTNEXT Ahmed F. Abdel-Magid* Cite this: ACS Med. Chem. Lett. 2021, 12, 8, 1188–1190…

Freedom WaresAugust 21, 2021

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis.

Biochem Pharmacol. 2018 Aug 1. pii: S0006-2952(18)30317-4. doi: 10.1016/j.bcp.2018.07.047. García-Martín A1, Garrido-Rodríguez M2, Navarrete C1,…

Freedom WaresAugust 4, 2018

Canna~Fangled Abstracts

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.

2016 Feb 18;6:21703. doi: 10.1038/srep21703.Del Río C1, Navarrete C2, Collado JA2, Bellido ML2, Gómez-Cañas M3,4,5, Pazos MR3,4,5, Fernández-Ruiz J3,4,5, Pollastro F6, Appendino G6, Calzado…

Freedom WaresFebruary 18, 2016

fibrotic diseases

Cannabinoid Receptor Agonists for the Potential Treatment of Pain, Neurological Disorders, Fibrotic Diseases, Obesity, and Many More

EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis.

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.

Recent Posts

Archives

Categories